Cargando…
KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer
KRAS is a driver mutation for malignant transformation. It is found in 30% of all cancers and in 90% of pancreatic cancers. The identification of small molecules selectively inhibiting KRAS mutants has been challenging, yet mutant KRAS has recently been shown to be targeted by tumor-infiltrating lym...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156365/ https://www.ncbi.nlm.nih.gov/pubmed/30283732 http://dx.doi.org/10.3389/fonc.2018.00384 |